75 related articles for article (PubMed ID: 9541968)
1. [The role of "growth" domain of urokinase in migration of smooth muscle cells].
Stepanova VV; Goncharova EA; Bibilashvili RSh; Tkachuk VA
Ross Fiziol Zh Im I M Sechenova; 1997; 83(11-12):158-67. PubMed ID: 9541968
[TBL] [Abstract][Full Text] [Related]
2. Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains.
Poliakov AA; Mukhina SA; Traktouev DO; Bibilashvily RS; Gursky YG; Minashkin MM; Stepanova VV; Tkachuk VA
J Recept Signal Transduct Res; 1999 Nov; 19(6):939-51. PubMed ID: 10533982
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.
Stepanova V; Mukhina S; Köhler E; Resink TJ; Erne P; Tkachuk VA
Mol Cell Biochem; 1999 May; 195(1-2):199-206. PubMed ID: 10395084
[TBL] [Abstract][Full Text] [Related]
4. Urokinase plasminogen activator induces smooth muscle cell migration: key role of growth factor-like domain.
Stepanova V; Bobik A; Bibilashvily R; Belogurov A; Rybalkin I; Domogatsky S; Little PJ; Goncharova E; Tkachuk V
FEBS Lett; 1997 Sep; 414(2):471-4. PubMed ID: 9315743
[TBL] [Abstract][Full Text] [Related]
5. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis.
Mukhina S; Stepanova V; Traktouev D; Poliakov A; Beabealashvilly R; Gursky Y; Minashkin M; Shevelev A; Tkachuk V
J Biol Chem; 2000 Jun; 275(22):16450-8. PubMed ID: 10749881
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
7. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
Wells JM; Strickland S
J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
[TBL] [Abstract][Full Text] [Related]
8. [Expression of urokinase and its receptor correlate with proliferation of smooth muscle cell in injured arteries].
Plekhanova OS; Kalinina NI; Volynskaia EA; Parfenova EV
Ross Fiziol Zh Im I M Sechenova; 2000 Jan; 86(1):18-27. PubMed ID: 10740832
[TBL] [Abstract][Full Text] [Related]
9. Augmented urokinase receptor expression in atheroma.
Noda-Heiny H; Daugherty A; Sobel BE
Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):37-43. PubMed ID: 7749814
[TBL] [Abstract][Full Text] [Related]
10. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
Kiyan J; Haller H; Dumler I
Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
[TBL] [Abstract][Full Text] [Related]
12. Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domain.
Stratton-Thomas JR; Min HY; Kaufman SE; Chiu CY; Mullenbach GT; Rosenberg S
Protein Eng; 1995 May; 8(5):463-70. PubMed ID: 8532668
[TBL] [Abstract][Full Text] [Related]
13. Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders.
Kanse SM; Benzakour O; Kanthou C; Kost C; Lijnen HR; Preissner KT
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2848-54. PubMed ID: 9409265
[TBL] [Abstract][Full Text] [Related]
14. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
[TBL] [Abstract][Full Text] [Related]
15. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.
Niedbala MJ; Bajetta S; Carbone R; Sartorelli AC
Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831
[TBL] [Abstract][Full Text] [Related]
18. UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1.
Lugano R; Peña E; Casani L; Badimon L; Padró T
Cardiovasc Res; 2013 Nov; 100(2):262-71. PubMed ID: 23812296
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-expressed urokinase regulates human vascular smooth muscle cell migration in a coculture model.
Kusch A; Tkachuk S; Lutter S; Haller H; Dietz R; Lipp M; Dumler I
Biol Chem; 2002 Jan; 383(1):217-21. PubMed ID: 11928816
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation.
Ploug M; Ostergaard S; Hansen LB; Holm A; Danø K
Biochemistry; 1998 Mar; 37(11):3612-22. PubMed ID: 9521680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]